标题
Proof of principle for epitope-focused vaccine design
作者
关键词
-
出版物
NATURE
Volume 507, Issue 7491, Pages 201-206
出版商
Springer Nature
发表日期
2014-02-05
DOI
10.1038/nature12966
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
- (2013) Michele D Tameris et al. LANCET
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Distribution of Respiratory Syncytial Virus Subtypes A and B Among Infants Presenting to the Emergency Department With Lower Respiratory Tract Infection or Apnea
- (2013) Hasan S. Jafri et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Strategic priorities for respiratory syncytial virus (RSV) vaccine development
- (2013) L.J. Anderson et al. VACCINE
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Christopher J L Murray et al. LANCET
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Principles for designing ideal protein structures
- (2012) Nobuyasu Koga et al. NATURE
- Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site
- (2012) Xiaolin Wen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
- (2012) D. R. Burton et al. SCIENCE
- High-Resolution Definition of Vaccine-Elicited B Cell Responses Against the HIV Primary Receptor Binding Site
- (2012) C. Sundling et al. Science Translational Medicine
- Analysis of Respiratory Syncytial Virus Preclinical and Clinical Variants Resistant to Neutralization by Monoclonal Antibodies Palivizumab and/or Motavizumab
- (2011) Qing Zhu et al. JOURNAL OF INFECTIOUS DISEASES
- Design and Characterization of Epitope-Scaffold Immunogens That Present the Motavizumab Epitope from Respiratory Syncytial Virus
- (2011) Jason S. McLellan et al. JOURNAL OF MOLECULAR BIOLOGY
- Computational Design of High-Affinity Epitope Scaffolds by Backbone Grafting of a Linear Epitope
- (2011) Mihai L. Azoitei et al. JOURNAL OF MOLECULAR BIOLOGY
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
- (2011) Michael T Osterholm et al. LANCET INFECTIOUS DISEASES
- Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
- (2011) M. L. Azoitei et al. SCIENCE
- A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate
- (2010) M. Chen et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Computational Protein Design Using Flexible Backbone Remodeling and Resurfacing: Case Studies in Structure-Based Antigen Design
- (2010) Bruno E. Correia et al. JOURNAL OF MOLECULAR BIOLOGY
- Structural basis of respiratory syncytial virus neutralization by motavizumab
- (2010) Jason S McLellan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Elicitation of structure-specific antibodies by epitope scaffolds
- (2010) G. Ofek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RosettaHoles2: A volumetric packing measure for protein structure refinement and validation
- (2010) William Sheffler et al. PROTEIN SCIENCE
- Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope
- (2010) Bruno E. Correia et al. STRUCTURE
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started